Argenx announces results of annual general meeting of shareholders

May 1 1 , 20 2 1 breda, the netherlands – argenx se (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that the proposed resolutions presented at its annual general meeting of shareholders, held today at 10:00 a.m. cest, were duly passed.

ARGX Ratings Summary

ARGX Quant Ranking